Home The Word Brain	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Ear2Memory – Free App | Free PDF | Web Learning languages on your smartphone By BSK	Free Abstracts

Prostate Cancer

Free Subscription 31.07.2017 1 Acta Radiol 1 AJR Am J Roentgenol 3 Am J Surg Pathol 2 Anticancer Res 4 BJU Int 2 BMC Cancer 1 Br J Radiol 2 Cancer Res 2 Clin Cancer Res 4 Eur Urol 1 Int J Cancer 6 Int J Radiat Oncol Biol Phys 1 Int J Urol 1 J Clin Oncol 2 J Nucl Med 5 J Urol 1 Lancet Oncol 1 N Engl J Med 1 Nat Rev Urol 1 Oncogene 1 Oncol Rep 4 Prostate 1 Ther Adv Urol 1 Urology

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Acta Radiol

1. ELKJAER MC, Andersen MH, Hoyer S, Pedersen BG, et al
   Prostate cancer: in-bore magnetic resonance guided biopsies at active surveillance inclusion improve selection of patients for active treatment.
   Acta Radiol. 2017 Jan 1:284185117723372. doi: 10.1177/0284185117723372.
   PubMed     Text format     Abstract available
   
   

   
   AJR Am J Roentgenol

2. SHERIDAN AD, Nath SK, Huber S, Rosasco S, et al
   Role of MRI in the Use of an Absorbable Hydrogel Spacer in Men Undergoing Radiation Therapy for Prostate Cancer: What the Radiologist Needs to Know.
   AJR Am J Roentgenol. 2017 Jul 25:1-3. doi: 10.2214/AJR.17.18026.
   PubMed     Text format     Abstract available
   
   

   
   Am J Surg Pathol

3. WOBKER SE, Khararjian A, Epstein JI
   GATA3 Positivity in Benign Radiated Prostate Glands: A Potential Diagnostic Pitfall.
   Am J Surg Pathol. 2017;41:557-563.
   PubMed     Text format     Abstract available
   
   
4. EPSTEIN JI, Amin MB, Reuter VE, Humphrey PA, et al
   Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
   Am J Surg Pathol. 2017;41:e1-e7.
   PubMed     Text format     Abstract available
   
   
5. HICKMAN RA, Yu H, Li J, Kong M, et al
   Atypical Intraductal Cribriform Proliferations of the Prostate Exhibit Similar Molecular and Clinicopathologic Characteristics as Intraductal Carcinoma of the Prostate.
   Am J Surg Pathol. 2017;41:550-556.
   PubMed     Text format     Abstract available
   
   

   
   Anticancer Res

6. YU S, Jiang Y, Wan F, Wu J, et al
   Immortalized Cancer-associated Fibroblasts Promote Prostate Cancer Carcinogenesis, Proliferation and Invasion.
   Anticancer Res. 2017;37:4311-4318.
   PubMed     Text format     Abstract available
   
   
7. LIN C, Wang J, Wang Y, Zhu P, et al
   GRP78 Participates in PCA3-regulated Prostate Cancer Progression.
   Anticancer Res. 2017;37:4303-4310.
   PubMed     Text format     Abstract available
   
   

   
   BJU Int

8. SUJENTHIRAN A, Charman SC, Parry M, Nossiter J, et al
   Quantifying severe urinary complications after radical prostatectomy: the development and validation of a surgical performance indicator using hospital administrative data.
   BJU Int. 2017;120:219-225.
   PubMed     Text format     Abstract available
   
   
9. ONG WL, Foroudi F, Evans S, Millar J, et al
   Large institutional variations in androgen deprivation therapy utilization with definitive radiotherapy in a population-based cohort of men with intermediate- and high-risk prostate cancer.
   BJU Int. 2017 Jul 27. doi: 10.1111/bju.13969.
   PubMed     Text format     Abstract available
   
   
10. KADONO Y, Machioka K, Nakashima K, Iijima M, et al
    Changes in penile length after radical prostatectomy: investigation of the underlying anatomical mechanism.
    BJU Int. 2017;120:293-299.
    PubMed     Text format     Abstract available
    
    
11. PAVLOVICH CP, Rocco B, Druskin SC, Davis JW, et al
    Urinary continence recovery after radical prostatectomy - anatomical/reconstructive and nerve-sparing techniques to improve outcomes.
    BJU Int. 2017;120:185-196.
    PubMed     Text format     Abstract available
    
    

    
    BMC Cancer

12. JACOBSEN F, Taskin B, Melling N, Sauer C, et al
    Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer.
    BMC Cancer. 2017;17:504.
    PubMed     Text format     Abstract available
    
    
13. CRAWLEY D, Chandra A, Loda M, Gillett C, et al
    Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer.
    BMC Cancer. 2017;17:494.
    PubMed     Text format     Abstract available
    
    

    
    Br J Radiol

14. SAMLALI H, Udrescu C, Lapierre A, Enachescu C, et al
    Prospective evaluation of a specific technique of sexual function preservation in external beam radiotherapy for prostate cancer.
    Br J Radiol. 2017 Jul 27:20160877. doi: 10.1259/bjr.20160877.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Res

15. MANZO T, Sturmheit T, Basso V, Petrozziello E, et al
    T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFalpha Expression and Empower Adoptive Cell Therapy for Solid Tumors.
    Cancer Res. 2017;77:658-671.
    PubMed     Text format     Abstract available
    
    
16. BERNICHTEIN S, Pigat N, Barry Delongchamps N, Boutillon F, et al
    Vitamin D3 Prevents Calcium-Induced Progression of Early-Stage Prostate Tumors by Counteracting TRPC6 and Calcium Sensing Receptor Upregulation.
    Cancer Res. 2017;77:355-365.
    PubMed     Text format     Abstract available
    
    

    
    Clin Cancer Res

17. SEED G, Yuan W, Mateo J, Carreira S, et al
    Gene Copy Number Estimation From Targeted Next Generation Sequencing Of Prostate Cancer Biopsies: Analytic Validation and Clinical Qualification.
    Clin Cancer Res. 2017 Jul 27. pii: clincanres.0972.2017.
    PubMed     Text format     Abstract available
    
    
18. GAO WQ, Guo Y, Zhang K, Cheng C, et al
    Numb-/low enriches a castration resistant prostate cancer cell subpopulation associated with enhanced Notch and Hedgehog signaling.
    Clin Cancer Res. 2017 Jul 27. pii: clincanres.0913.2017.
    PubMed     Text format     Abstract available
    
    

    
    Eur Urol

19. TREE A, Dearnaley D
    Randomised Controlled Trials Remain the Key to Progress in Localised Prostate Cancer.
    Eur Urol. 2017 Jul 21. pii: S0302-2838(17)30590.
    PubMed     Text format    
    
    
20. CARAM MEV, Miller DC
    Treating Advanced Prostate Cancer-the Human Factor.
    Eur Urol. 2017 Jul 18. pii: S0302-2838(17)30585.
    PubMed     Text format    
    
    
21. PENSON DF
    Quality of Life Outcomes Following Treatment for Localized Prostate Cancer: What's New and What's Not.
    Eur Urol. 2017 Jul 20. pii: S0302-2838(17)30588.
    PubMed     Text format    
    
    
22. CROOK J
    Optimal Radiotherapy for Unfavorable-risk Prostate Cancer.
    Eur Urol. 2017 Jul 21. pii: S0302-2838(17)30589.
    PubMed     Text format    
    
    

    
    Int J Cancer

23. LIN HM, Mahon KL, Weir JM, Mundra PA, et al
    A distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancer: Authors.
    Int J Cancer. 2017 Jul 25. doi: 10.1002/ijc.30903.
    PubMed     Text format     Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

24. CHARGARI C, Haie-Meder C, Guerin F, Minard-Colin V, et al
    Brachytherapy Combined With Surgery for Conservative Treatment of Children With Bladder Neck and/or Prostate Rhabdomyosarcoma.
    Int J Radiat Oncol Biol Phys. 2017;98:352-359.
    PubMed     Text format     Abstract available
    
    
25. FANG P, He W, Gomez DR, Hoffman KE, et al
    Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States.
    Int J Radiat Oncol Biol Phys. 2017;98:748-757.
    PubMed     Text format     Abstract available
    
    
26. MIDDELBURG JG, Mast ME, de Kroon M, Jobsen JJ, et al
    Timed Get Up and Go Test and Geriatric 8 Scores and the Association With (Chemo-)Radiation Therapy Noncompliance and Acute Toxicity in Elderly Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2017;98:843-849.
    PubMed     Text format     Abstract available
    
    
27. SONG YP, Ellis T, Walshaw R, Mbanu P, et al
    Comparing Clinical Outcomes for Radium-223: Do Older Patients Do Worse?
    Int J Radiat Oncol Biol Phys. 2017;98:955-957.
    PubMed     Text format     Abstract available
    
    
28. GAY HA, Sanda MG, Liu J, Wu N, et al
    External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy: Results of a Multicenter, Prospective Study of Quality of Life.
    Int J Radiat Oncol Biol Phys. 2017;98:304-317.
    PubMed     Text format     Abstract available
    
    
29. WAHL DR, Nguyen PL, Santiago M, Yousefi K, et al
    Pan-Cancer Analysis of Genomic Sequencing Among the Elderly.
    Int J Radiat Oncol Biol Phys. 2017;98:726-732.
    PubMed     Text format     Abstract available
    
    

    
    Int J Urol

30. DINH KT, Yang DD, Nead KT, Reznor G, et al
    Association between androgen deprivation therapy and anxiety among 78 000 patients with localized prostate cancer.
    Int J Urol. 2017 Jul 22. doi: 10.1111/iju.13409.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Oncol

31. OUDARD S, Fizazi K, Sengelov L, Daugaard G, et al
    Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA.
    J Clin Oncol. 2017 Jul 28:JCO2016721068. doi: 10.1200/JCO.2016.72.1068.
    PubMed     Text format     Abstract available
    
    

    
    J Nucl Med

32. AFAQ A, Alahmed S, Chen SH, Lengana T, et al
    68Ga-PSMA PET/CT impact on prostate cancer management.
    J Nucl Med. 2017 Jul 26. pii: jnumed.117.192625. doi: 10.2967/jnumed.117.192625.
    PubMed     Text format     Abstract available
    
    
33. GRIVAS N, Wit E, Kuusk T, KleinJan G, et al
    The impact of adding sentinel node biopsy to extended pelvic lymph node dissection on the biochemical recurrence of prostate cancer patients treated with robot-assisted radical prostatectomy.
    J Nucl Med. 2017 Jul 26. pii: jnumed.117.195644. doi: 10.2967/jnumed.117.195644.
    PubMed     Text format     Abstract available
    
    

    
    J Urol

34. CHANG E, Jones TA, Natarajan S, Sharma D, et al
    Value of Tracking Biopsy in Men Undergoing Active Surveillance of Prostate Cancer.
    J Urol. 2017 Jul 17. pii: S0022-5347(17)77144-3. doi: 10.1016/j.juro.2017.
    PubMed     Text format     Abstract available
    
    
35. YANG L, Kibel AS, Colditz GA, Pakpahan R, et al
    Caution with Use of the Expanded Prostate Cancer Index Composite-50 Urinary Bother Scale: How Voiding Dysfunction Modifies Its Performance.
    J Urol. 2017 Jul 17. pii: S0022-5347(17)77147-9. doi: 10.1016/j.juro.2017.
    PubMed     Text format     Abstract available
    
    
36. GORIN MA, Rowe SP, Patel HD, Vidal I, et al
    PSMA-targeted 18F-DCFPyL PET/CT in the Preoperative Staging of Men with High-risk Prostate Cancer: Results of a Prospective Phase II Single-Center Study.
    J Urol. 2017 Jul 20. pii: S0022-5347(17)77186-8. doi: 10.1016/j.juro.2017.
    PubMed     Text format     Abstract available
    
    
37. TAMMELA TL, Haggman M, Ladjevardi S, Taari K, et al
    An Intraprostatic Modified Release Formulation of Antiandrogen 2-Hydroxyflutamide for Localized Prostate Cancer.
    J Urol. 2017 Jul 20. pii: S0022-5347(17)77188-1. doi: 10.1016/j.juro.2017.
    PubMed     Text format     Abstract available
    
    
38. TAPLIN ME, Armstrong AJ, Lin P, Krivoshik A, et al
    Clinical Outcomes of Chemotherapy-Naive Men with Metastatic Castration-Resistant Prostate Cancer and Low Baseline PSA Treated with Enzalutamide vs Placebo.
    J Urol. 2017 Jul 20. pii: S0022-5347(17)77187-X. doi: 10.1016/j.juro.2017.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Oncol

39. DAS M
    Surgery no better than observation for localised prostate cancer.
    Lancet Oncol. 2017 Jul 20. pii: S1470-2045(17)30565.
    PubMed     Text format    
    
    

    
    N Engl J Med

40. LOGOTHETIS CJ
    Improved Outcomes in Men with Advanced Prostate Cancer.
    N Engl J Med. 2017;377:388-390.
    PubMed     Text format    
    
    

    
    Nat Rev Urol

41. THOMA C
    Prostate cancer: Subtype linked to germline variant.
    Nat Rev Urol. 2017 Jul 25. doi: 10.1038/nrurol.2017.
    PubMed     Text format    
    
    

    
    Oncogene

42. D'ABRONZO LS, Bose S, Crapuchettes ME, Beggs RE, et al
    The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer.
    Oncogene. 2017 Jul 24. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available
    
    

    
    Oncol Rep

43. GAO C, Zhou Y, Jiang Z, Zhao Y, et al
    Cytotoxic and chemosensitization effects of Scutellarin from traditional Chinese herb Scutellaria altissima L. in human prostate cancer cells.
    Oncol Rep. 2017 Jul 24. doi: 10.3892/or.2017.5850.
    PubMed     Text format     Abstract available
    
    

    
    Prostate

44. LIN X, Chen Z, Gao P, Gao Z, et al
    TEX15: A DNA repair gene associated with prostate cancer risk in Han Chinese.
    Prostate. 2017 Jul 21. doi: 10.1002/pros.23387.
    PubMed     Text format     Abstract available
    
    
45. SHARPE B, Alghezi DA, Cattermole C, Beresford M, et al
    A subset of high Gleason grade prostate carcinomas contain a large burden of prostate cancer syndecan-1 positive stromal cells.
    Prostate. 2017 Jul 26. doi: 10.1002/pros.23391.
    PubMed     Text format     Abstract available
    
    
46. FAN L, Wang X, Chi C, Wang Y, et al
    Prognostic nutritional index predicts initial response to treatment and prognosis in metastatic castration-resistant prostate cancer patients treated with abiraterone.
    Prostate. 2017 Jul 28. doi: 10.1002/pros.23381.
    PubMed     Text format     Abstract available
    
    
47. SUN G, Huang R, Zhang X, Shen P, et al
    The impact of multifocal perineural invasion on biochemical recurrence and timing of adjuvant androgen-deprivation therapy in high-risk prostate cancer following radical prostatectomy.
    Prostate. 2017 Jul 27. doi: 10.1002/pros.23388.
    PubMed     Text format     Abstract available
    
    

    
    Ther Adv Urol

48. GIL T, Aoun F, Cabri P, Perrot V, et al
    Triptorelin for the relief of lower urinary tract symptoms in men with advanced prostate cancer: results of a prospective, observational, grouped-analysis study.
    Ther Adv Urol. 2017;9:179-190.
    PubMed     Text format     Abstract available
    
    

    
    Urology

49. HORIGUCHI A, Shinchi M, Nakamura A, Wada T, et al
    Pilot Study of Prostate Cancer Angiogenesis Imaging Using a Photoacoustic Imaging System.
    Urology. 2017 Jul 19. pii: S0090-4295(17)30733.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: